Glenview Trust’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Buy
4,335
+12
+0.3% +$875 ﹤0.01% 428
2026
Q1
$282K Sell
4,323
-120
-3% -$8.91K ﹤0.01% 437
2025
Q4
$352K Sell
4,443
-114
-3% -$8.73K 0.01% 412
2025
Q3
$333K Sell
4,557
-1
-0% -$73 0.01% 414
2025
Q2
$346K Sell
4,558
-150
-3% -$10.6K 0.01% 409
2025
Q1
$358K Sell
4,708
-231
-5% -$17.2K 0.01% 389
2024
Q4
$326K Sell
4,939
-679
-12% -$47.5K 0.01% 403
2024
Q3
$392K Sell
5,618
-604
-10% -$36.3K 0.01% 383
2024
Q2
$329K Buy
+6,222
New +$378K 0.01% 393

Other funds holding SOLV

Glenview Trust's SOLV Position: Q2 2026 in Review

Glenview Trust increased its Solventum (SOLV) stake by 0.28% in Q2 2026, buying an estimated $875 and bringing the position to 4,335 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Glenview Trust first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $392K in Q3 2024. 878 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Glenview Trust held 4,335 shares of Solventum worth $334K as of Q2 2026.
  • Glenview Trust bought 12 Solventum shares in Q2 2026, an estimated $875.
  • Solventum made up ﹤0.01% of Glenview Trust's portfolio in Q2 2026, its #428 holding.
  • Glenview Trust first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • Glenview Trust's Solventum position peaked at $392K in Q3 2024.
  • 878 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.